US07725L1026
US07725L1026
BeOne Medicines Ltd.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 40.33B EUR | 418.83B EUR | 429.15B EUR | 437.81B EUR |
Enterprise Value | 36.76B EUR | 414.87B EUR | 425.5B EUR | 434.36B EUR |
Valuation Multiples | ||||
Trailing P/E | 63.41x | 638.74x | 836.51x | 1,532.62x |
Forward P/E | 34.58x | -- | -- | -- |
Price to Sales | 6.58x | 68.34x | 74.77x | 103.61x |
Price to Book | 7.74x | 80.95x | 90.15x | 100.39x |
EV/Revenue | 6x | 67.69x | 74.14x | 102.79x |
EV/EBITDA | 34.31x | 352.98x | 459.62x | 733.06x |
Price to FCF (P/FCF) | 45.88x | 319.97x | 392.3x | 469.06x |
EV/FCF | 41.82x | 316.94x | 388.97x | 465.36x |
FCF Yield | 2.18% | 0.31% | 0.25% | 0.21% |